Erythromycin

Antibiotic use in obstetrics and gynecology

Patrick Duff, guest editor

Expanding indications for the new macrolides, azalides, and streptogramins

edited by Stephen H. Zinner ... [et al.].

FDA approved registration of erythromycin for treatment of bacterial kidney disease (BKD) in juvenile and adult chinook salmon: annual report, reporting period: year 1, 10 March 1989 - 9 March 1990

prepared by Christine A. Moffitt.

Erythromycin.

Foreword by Henry Welch and Félix Martí-Ibáñez.

Comparative study of erythromycin, amoxicillin and ampicillin antimicrobial activity against human respiratory tract pathogens

by Robert H. Liss, John C. Norman and Donald A. Goldmann.

I. The total synthesis of erythronolide A ; II. The total synthesis and stereochemical assignment of two eicosanoids, LTB and 5,12-di-HETE

by Paul Brink Hopkins

Informing patients about drugs--analysis of alternative designs for erythromycin leaflets

John D. Winkler ... [et al.] ; prepared for the Food and Drug Administration.

Erythromycin: a review of its properties and clinical status.

Biosynthesis of erythromycin: I. Isolation of acyl-CoA carboxylase. II. Malonyl-CoA decarboxylase; purification properties and its role in the production of erythromycin

by Abdelrahim A. Alali Hunaiti.

NTP technical report on the toxicology and carcinogenesis studies of Erythromycin stearate (CAS no. 643-22-1) in F344/N rats and B6C3F1 mice (feed studies)

National Toxicology Program